CoChat

Extracellular Vesicles from Red Blood Cells and Their Evolving Roles in Health, Coagulopathy and Therapy

Open access
Thangaraju, Kiruphagaran, Neerukonda, Sabari Nath, Katneni, Upendra, Buehler, Paul W. · 2020 · International Journal of Molecular Sciences
Cited by 164

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Abstract

Red blood cells (RBCs) release extracellular vesicles (EVs) including both endosome-derived exosomes and plasma-membrane-derived microvesicles (MVs). RBC-derived EVs (RBCEVs) are secreted during erythropoiesis, physiological cellular aging, disease conditions, and in response to environmental stressors. RBCEVs are enriched in various bioactive molecules that facilitate cell to cell communication and can act as markers of disease. RBCEVs contribute towards physiological adaptive responses to hypoxia as well as pathophysiological progression of diabetes and genetic non-malignant hematologic disease. Moreover, a considerable number of studies focus on the role of EVs from stored RBCs and have evaluated post transfusion consequences associated with their exposure. Interestingly, RBCEVs are important contributors toward coagulopathy in hematological disorders, thus representing a unique evolving area of study that can provide insights into molecular mechanisms that contribute toward dysregulated hemostasis associated with several disease conditions. Relevant work to this point provides a foundation on which to build further studies focused on unraveling the potential roles of RBCEVs in health and disease. In this review, we provide an analysis and summary of RBCEVs biogenesis, composition, and their biological function with a special emphasis on RBCEV pathophysiological contribution to coagulopathy. Further, we consider potential therapeutic applications of RBCEVs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms22010153

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 24 references

Research works printed but not linked: 216

  1. Horder, 1899, Blood dust or blood granules: A new constituent of the blood?, Lancet, 154, 1015, 10.1016/S0140-6736(01)59201-6 · doi:10.1016/s0140-6736(01)59201-6
  2. Nguyen, D.B., Ly, T.B.T., and Bernhardt, I. (2017). Microvesicles Released from Human Red Blood Cells: Properties and Potential Applications, IntechOpen. · DOI
  3. Szatanek, R., Baj-Krzyworzeka, M., Zimoch, J., Lekka, M., Siedlar, M., and Baran, J. (2017). The Methods of Choice for Extracellular Vesicles (EVs) Characterization. Int. J. Mol. Sci., 18. · DOI · Paper page
  4. Pan, 1983, Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro: Selective externalization of the receptor, Cell, 33, 967, 10.1016/0092-8674(83)90040-5 · DOI · Paper page
  5. Buschow, 2009, MHC II in dendritic cells is targeted to lysosomes or T cell-induced exosomes via distinct multivesicular body pathways, Traffic, 10, 1528, 10.1111/j.1600-0854.2009.00963.x · DOI · Paper page
  6. Theos, 2006, A lumenal domain-dependent pathway for sorting to intralumenal vesicles of multivesicular endosomes involved in organelle morphogenesis, Dev. Cell, 10, 343, 10.1016/j.devcel.2006.01.012 · DOI · Paper page
  7. Baixauli, 2016, ISGylation controls exosome secretion by promoting lysosomal degradation of MVB proteins, Nat. Commun., 7, 13588, 10.1038/ncomms13588 · DOI · Paper page
  8. Guix, 2017, Tetraspanin 6: A pivotal protein of the multiple vesicular body determining exosome release and lysosomal degradation of amyloid precursor protein fragments, Mol. Neurodegener., 12, 25, 10.1186/s13024-017-0165-0 · DOI · Paper page
  9. Tamai, 2010, Exosome secretion of dendritic cells is regulated by Hrs, an ESCRT-0 protein, Biochem. Biophys. Res. Commun., 399, 384, 10.1016/j.bbrc.2010.07.083 · DOI · Paper page
  10. Blanc, 2009, The water channel aquaporin-1 partitions into exosomes during reticulocyte maturation: Implication for the regulation of cell volume, Blood, 114, 3928, 10.1182/blood-2009-06-230086 · DOI · Paper page
  11. Wolf, 1967, The nature and significance of platelet products in human plasma, Br. J. Haematol., 13, 269, 10.1111/j.1365-2141.1967.tb08741.x · DOI · Paper page
  12. Hristov, 2004, Apoptotic bodies from endothelial cells enhance the number and initiate the differentiation of human endothelial progenitor cells in vitro, Blood, 104, 2761, 10.1182/blood-2003-10-3614 · DOI · Paper page
  13. Hurley, 2010, Membrane budding and scission by the ESCRT machinery: It’s all in the neck, Nat. Rev. Mol. Cell Biol., 11, 556, 10.1038/nrm2937 · DOI · Paper page
  14. Penalva, M. (2002). Faculty Opinions recommendation of Escrt-III: An endosome-associated heterooligomeric protein complex required for mvb sorting. Fac. Opin. Post Publ. Peer Rev. Biomed. Lit. · doi:10.3410/f.1009409.126008
  15. Babst, 2002, Endosome-associated complex, ESCRT-II, recruits transport machinery for protein sorting at the multivesicular body, Dev. Cell, 3, 283, 10.1016/S1534-5807(02)00219-8 · DOI · Paper page
  16. Bilodeau, 2003, Vps27-Hse1 and ESCRT-I complexes cooperate to increase efficiency of sorting ubiquitinated proteins at the endosome, J. Cell Biol., 163, 237, 10.1083/jcb.200305007 · DOI · Paper page
  17. Katzmann, 2001, Ubiquitin-dependent sorting into the multivesicular body pathway requires the function of a conserved endosomal protein sorting complex, ESCRT-I, Cell, 106, 145, 10.1016/S0092-8674(01)00434-2 · DOI · Paper page
  18. Katzmann, 2003, Vps27 recruits ESCRT machinery to endosomes during MVB sorting, J. Cell Biol., 162, 413, 10.1083/jcb.200302136 · DOI · Paper page
  19. Stuffers, 2009, Multivesicular endosome biogenesis in the absence of ESCRTs, Traffic, 10, 925, 10.1111/j.1600-0854.2009.00920.x · DOI · Paper page
  20. Charrin, 2011, The tetraspanin CD63 regulates ESCRT-independent and -dependent endosomal sorting during melanogenesis, Dev. Cell, 21, 708, 10.1016/j.devcel.2011.08.019 · DOI · Paper page
  21. Trajkovic, 2008, Ceramide triggers budding of exosome vesicles into multivesicular endosomes, Science, 319, 1244, 10.1126/science.1153124 · DOI · Paper page
  22. Jorge, 2013, The intracellular interactome of tetraspanin-enriched microdomains reveals their function as sorting machineries toward exosomes, J. Biol. Chem., 288, 11649, 10.1074/jbc.M112.445304 · DOI · Paper page
  23. Kajimoto, 2013, Ongoing activation of sphingosine 1-phosphate receptors mediates maturation of exosomal multivesicular endosomes, Nat. Commun., 4, 2712, 10.1038/ncomms3712 · DOI · Paper page
  24. Bergam, 2015, Apolipoprotein E Regulates Amyloid Formation within Endosomes of Pigment Cells, Cell Rep., 13, 43, 10.1016/j.celrep.2015.08.057 · DOI · Paper page
  25. Gauthier, 2017, Enhanced exosome secretion in Down syndrome brain—A protective mechanism to alleviate neuronal endosomal abnormalities, Acta Neuropathol. Commun., 5, 65, 10.1186/s40478-017-0466-0 · DOI · Paper page
  26. Odintsova, 2013, Metastasis suppressor tetraspanin CD82/KAI1 regulates ubiquitylation of epidermal growth factor receptor, J. Biol. Chem., 288, 26323, 10.1074/jbc.M112.439380 · DOI · Paper page
  27. Vidal, 1997, Aggregation reroutes molecules from a recycling to a vesicle-mediated secretion pathway during reticulocyte maturation, J. Cell Sci., 110, 1867, 10.1242/jcs.110.16.1867 · DOI · Paper page
  28. Blanc, 2005, Exosome release by reticulocytes—An integral part of the red blood cell differentiation system, Blood Cells Mol. Dis., 35, 21, 10.1016/j.bcmd.2005.04.008 · DOI
  29. Ney, 2011, Normal and disordered reticulocyte maturation, Curr. Opin. Hematol., 18, 152, 10.1097/MOH.0b013e328345213e · DOI · Paper page
  30. 2018, Proteomics study of human cord blood reticulocyte-derived exosomes, Sci. Rep., 8, 14046, 10.1038/s41598-018-32386-2 · DOI
  31. Carayon, 2011, Proteolipidic composition of exosomes changes during reticulocyte maturation, J. Biol. Chem., 286, 34426, 10.1074/jbc.M111.257444 · DOI · Paper page
  32. Bryk, 2017, Quantitative Analysis of Human Red Blood Cell Proteome, J. Prot. Res., 16, 2752, 10.1021/acs.jproteome.7b00025 · DOI · Paper page
  33. Leal, 2018, Red Blood Cell Homeostasis: Mechanisms and Effects of Microvesicle Generation in Health and Disease, Front. Physiol., 9, 703, 10.3389/fphys.2018.00703 · DOI
  34. Willekens, 2003, Hemoglobin loss from erythrocytes in vivo results from spleen-facilitated vesiculation, Blood, 101, 747, 10.1182/blood-2002-02-0500 · DOI
  35. Willekens, 1997, Quantification of loss of haemoglobin components from the circulating red blood cell in vivo, Eur. J. Haematol., 58, 246, 10.1111/j.1600-0609.1997.tb01662.x · DOI · Paper page
  36. Willekens, 2008, Erythrocyte vesiculation: A self-protective mechanism?, Br. J. Haematol., 141, 549, 10.1111/j.1365-2141.2008.07055.x · DOI · Paper page
  37. Bosman, 2012, The proteome of erythrocyte-derived microparticles from plasma: New clues for erythrocyte aging and vesiculation, J. Prot., 76, 203, 10.1016/j.jprot.2012.05.031 · DOI
  38. Lux, 2016, Anatomy of the red cell membrane skeleton: Unanswered questions, Blood, 127, 187, 10.1182/blood-2014-12-512772 · DOI · Paper page
  39. Ursitti, 1993, Ultrastructure and immunocytochemistry of the isolated human erythrocyte membrane skeleton, Cell Motil. Cytoskeleton, 25, 30, 10.1002/cm.970250105 · doi:10.1002/cm.970250105
  40. Liu, 1984, Oligomeric states of spectrin in normal erythrocyte membranes: Biochemical and electron microscopic studies, Cell, 37, 587, 10.1016/0092-8674(84)90389-1 · DOI
  41. Salomao, 2006, Mammalian alpha I-spectrin is a neofunctionalized polypeptide adapted to small highly deformable erythrocytes, Proc. Natl. Acad. Sci. USA, 103, 643, 10.1073/pnas.0507661103 · doi:10.1073/pnas.0507661103
  42. Picart, 2000, Actin protofilament orientation in deformation of the erythrocyte membrane skeleton, Biophys. J., 79, 2987, 10.1016/S0006-3495(00)76535-0 · DOI
  43. An, 2007, Tropomyosin modulates erythrocyte membrane stability, Blood, 109, 1284, 10.1182/blood-2006-07-036954 · DOI
  44. Moyer, 2010, Tropomodulin 1-null mice have a mild spherocytic elliptocytosis with appearance of tropomodulin 3 in red blood cells and disruption of the membrane skeleton, Blood, 116, 2590, 10.1182/blood-2010-02-268458 · DOI · Paper page
  45. Li, 1998, Adducin Preferentially Recruits Spectrin to the Fast Growing Ends of Actin Filaments in a Complex Requiring the MARCKS-related Domain and a Newly Defined Oligomerization Domain, J. Biol. Chem., 273, 19329, 10.1074/jbc.273.30.19329 · DOI
  46. Khan, 2008, Dematin and adducin provide a novel link between the spectrin cytoskeleton and human erythrocyte membrane by directly interacting with glucose transporter-1, J. Biol. Chem., 283, 14600, 10.1074/jbc.M707818200 · DOI
  47. Han, 2000, Protein 4.1R core domain structure and insights into regulation of cytoskeletal organization, Nat. Struct. Biol., 7, 871, 10.1038/82819 · DOI
  48. Manno, 2005, Modulation of erythrocyte membrane mechanical function by protein 4.1 phosphorylation, J. Biol. Chem., 280, 7581, 10.1074/jbc.M410650200 · doi:10.1074/jbc.m410650200
  49. Low, 1991, Contribution of the band 3-ankyrin interaction to erythrocyte membrane mechanical stability, Blood, 77, 1581, 10.1182/blood.V77.7.1581.1581 · DOI
  50. Westerman, 2008, Microvesicles in haemoglobinopathies offer insights into mechanisms of hypercoagulability, haemolysis and the effects of therapy, Br. J. Haematol., 142, 126, 10.1111/j.1365-2141.2008.07155.x · DOI · Paper page
  51. Ferru, 2014, Thalassemic erythrocytes release microparticles loaded with hemichromes by redox activation of p72Syk kinase, Haematologica, 99, 570, 10.3324/haematol.2013.084533 · DOI
  52. Daleke, 2008, Regulation of phospholipid asymmetry in the erythrocyte membrane, Curr. Opin. Hematol., 15, 191, 10.1097/MOH.0b013e3282f97af7 · DOI · Paper page
  53. Said, 2017, Physiologic Impact of Circulating RBC Microparticles upon Blood-Vascular Interactions, Front. Physiol., 8, 1120, 10.3389/fphys.2017.01120 · DOI
  54. Gonzalez, 2009, The influence of membrane physical properties on microvesicle release in human erythrocytes, PMC Biophys., 2, 7, 10.1186/1757-5036-2-7 · DOI
  55. Nguyen, 2016, Characterization of Microvesicles Released from Human Red Blood Cells, Cell. Physiol. Biochem., 38, 1085, 10.1159/000443059 · DOI
  56. Wesseling, 2016, Novel Insights in the Regulation of Phosphatidylserine Exposure in Human Red Blood Cells, Cell. Physiol. Biochem., 39, 1941, 10.1159/000447891 · doi:10.1159/000447891
  57. Lang, 2008, Eryptosis, a window to systemic disease, Cell. Physiol. Biochem., 22, 373, 10.1159/000185448 · DOI · Paper page
  58. Salzer, 2002, Ca++-dependent vesicle release from erythrocytes involves stomatin-specific lipid rafts, synexin (annexin VII), and sorcin, Blood, 99, 2569, 10.1182/blood.V99.7.2569 · DOI · Paper page
  59. Wesseling, 2016, Phosphatidylserine Exposure in Human Red Blood Cells Depending on Cell Age, Cell. Physiol. Biochem., 38, 1376, 10.1159/000443081 · DOI
  60. Sudnitsyna, J., Skverchinskaya, E., Dobrylko, I., Nikitina, E., Gambaryan, S., and Mindukshev, I. (2020). Microvesicle Formation Induced by Oxidative Stress in Human Erythrocytes. Antioxidants, 9. · doi:10.20944/preprints202008.0717.v1
  61. Stowell, 2013, Addition of ascorbic acid solution to stored murine red blood cells increases posttransfusion recovery and decreases microparticles and alloimmunization, Transfusion, 53, 2248, 10.1111/trf.12106 · DOI
  62. Kuo, 2012, ARRDC1 as a mediator of microvesicle budding, Proc. Natl. Acad. Sci. USA, 109, 4025, 10.1073/pnas.1201441109 · DOI
  63. Xu, B., Fu, Y., Liu, Y., Agvanian, S., Wirka, R.C., Baum, R., Zhou, K., Shaw, R.M., and Hong, T. (2017). The ESCRT-III pathway facilitates cardiomyocyte release of cBIN1-containing microparticles. PLoS Biol., 15. · DOI · Paper page
  64. Li, 2012, RhoA triggers a specific signaling pathway that generates transforming microvesicles in cancer cells, Oncogene, 31, 4740, 10.1038/onc.2011.636 · DOI · Paper page
  65. Wilson, 2013, Rho GTPases and their roles in cancer metabolism, Trends Mol. Med., 19, 74, 10.1016/j.molmed.2012.10.011 · DOI · Paper page
  66. Shrimpton, 2005, Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation, Blood, 106, 1604, 10.1182/blood-2004-03-1095 · DOI · Paper page
  67. Kim, 2015, EVpedia: A community web resource for prokaryotic and eukaryotic extracellular vesicles research, Semin. Cell Dev. Biol., 40, 4, 10.1016/j.semcdb.2015.02.005 · DOI
  68. Kim, D.-K., Kang, B., Kim, O.Y., Choi, D.-S., Lee, J., Kim, S.R., Go, G., Yoon, Y.J., Kim, J.H., and Jang, S.C. (2013). EVpedia: An integrated database of high-throughput data for systemic analyses of extracellular vesicles. J. Extracell. Vesicles, 2. · DOI · Paper page
  69. Keerthikumar, 2016, ExoCarta: A Web-Based Compendium of Exosomal Cargo, J. Mol. Biol., 428, 688, 10.1016/j.jmb.2015.09.019 · DOI · Paper page
  70. Prudent, 2018, Proteomics of Stored Red Blood Cell Membrane and Storage-Induced Microvesicles Reveals the Association of Flotillin-2 With Band 3 Complexes, Front. Physiol., 9, 421, 10.3389/fphys.2018.00421 · DOI
  71. Rubin, 2008, Microparticles in stored red blood cells: An approach using flow cytometry and proteomic tools, Vox Sang., 95, 288, 10.1111/j.1423-0410.2008.01101.x · DOI · Paper page
  72. Antonelou, 2016, Update on extracellular vesicles inside red blood cell storage units: Adjust the sails closer to the new wind, Transfus. Apher. Sci., 55, 92, 10.1016/j.transci.2016.07.016 · DOI
  73. Tissot, 2013, Blood microvesicles: From proteomics to physiology, Transl. Prot., 1, 38
  74. Hamilton, 2010, MicroRNA in erythrocytes, Biochem. Soc. Trans., 38, 229, 10.1042/BST0380229 · DOI · Paper page
  75. Aalto, 2012, Small non-coding RNAs mount a silent revolution in gene expression, Curr. Opin. Cell Biol., 24, 333, 10.1016/j.ceb.2012.03.006 · DOI
  76. Alder, 2012, miRNA profiling for biomarker discovery in multiple sclerosis: From microarray to deep sequencing, J. Neuroimmunol., 248, 32, 10.1016/j.jneuroim.2011.10.006 · DOI · Paper page
  77. Karius, 2012, MicroRNAs in cancer management and their modulation by dietary agents, Biochem. Pharmacol., 83, 1591, 10.1016/j.bcp.2012.02.004 · DOI
  78. Saki, 2015, Involvement of MicroRNA in T-Cell Differentiation and Malignancy, Int. J. Hematol. Oncol. Stem Cell Res., 9, 33
  79. Huang, 2019, MicroRNA Profiling of Exosomes Derived from Red Blood Cell Units: Implications in Transfusion-Related Immunomodulation, Biomed Res. Int., 2019, 2045915, 10.1155/2019/2045915 · DOI · Paper page
  80. Rasheed, 2019, Author Correction: MicroRNA-125b-5p regulates IL-1β induced inflammatory genes via targeting TRAF6-mediated MAPKs and NF-κB signaling in human osteoarthritic chondrocytes, Sci. Rep., 9, 14729, 10.1038/s41598-019-50844-3 · doi:10.1038/s41598-019-50844-3
  81. Diao, 2017, MicroRNA-125b-5p modulates the inflammatory state of macrophages via targeting B7-H4, Biochem. Biophys. Res. Commun., 491, 912, 10.1016/j.bbrc.2017.07.135 · DOI
  82. Yang, 2016, MicroRNA-125b-5p mimic inhibits acute liver failure, Nat. Commun., 7, 11916, 10.1038/ncomms11916 · DOI
  83. Morelli, 2015, Selective targeting of IRF4 by synthetic microRNA-125b-5p mimics induces anti-multiple myeloma activity in vitro and in vivo, Leukemia, 29, 2173, 10.1038/leu.2015.124 · DOI
  84. Doss, J.F., Corcoran, D.L., Jima, D.D., Telen, M.J., Dave, S.S., and Chi, J.-T. (2015). A comprehensive joint analysis of the long and short RNA transcriptomes of human erythrocytes. BMC Genomics, 16. · DOI · Paper page
  85. Sun, 2018, Different Erythrocyte MicroRNA Profiles in Low- and High-Altitude Individuals, Front. Physiol., 9, 1099, 10.3389/fphys.2018.01099 · DOI · Paper page
  86. Hua, Z., Lv, Q., Ye, W., Wong, C.-K.A., Cai, G., Gu, D., Ji, Y., Zhao, C., Wang, J., and Yang, B.B. (2006). MiRNA-directed regulation of VEGF and other angiogenic factors under hypoxia. PLoS ONE, 1. · DOI · Paper page
  87. Piriyapongsa, 2011, Transcription factor binding sites are highly enriched within microRNA precursor sequences, Biol. Direct, 6, 61, 10.1186/1745-6150-6-61 · DOI
  88. Hebert, 2007, High mobility group A2 is a target for miRNA-98 in head and neck squamous cell carcinoma, Mol. Cancer, 6, 5, 10.1186/1476-4598-6-5 · DOI · Paper page
  89. Juzenas, 2017, A comprehensive, cell specific microRNA catalogue of human peripheral blood, Nucleic Acids Res., 45, 9290, 10.1093/nar/gkx706 · DOI · Paper page
  90. Doherty, 1998, Rate of reaction with nitric oxide determines the hypertensive effect of cell-free hemoglobin, Nat. Biotechnol., 16, 672, 10.1038/nbt0798-672 · DOI · Paper page
  91. Donadee, 2011, Nitric Oxide Scavenging by Red Blood Cell Microparticles and Cell-Free Hemoglobin as a Mechanism for the Red Cell Storage Lesion, Circulation, 124, 465, 10.1161/CIRCULATIONAHA.110.008698 · DOI · Paper page
  92. Liu, 2013, Nitric oxide scavenging by red cell microparticles, Free Radic. Biol. Med., 65, 1164, 10.1016/j.freeradbiomed.2013.09.002 · DOI
  93. Herring, 2013, Microparticles in health and disease, J. Vet. Intern. Med., 27, 1020, 10.1111/jvim.12128 · DOI
  94. Poisson, 2020, Erythrocyte-derived microvesicles induce arterial spasms in JAK2V617F myeloproliferative neoplasm, J. Clin. Investig., 130, 2630, 10.1172/JCI124566 · DOI
  95. Harisa, 2017, Erythrocyte nanovesicles: Biogenesis, biological roles and therapeutic approach: Erythrocyte nanovesicles, Saudi Pharm. J., 25, 8, 10.1016/j.jsps.2015.06.010 · DOI
  96. Kuhn, 2017, Red Blood Cell Function and Dysfunction: Redox Regulation, Nitric Oxide Metabolism, Anemia, Antioxid. Redox Signal., 26, 718, 10.1089/ars.2016.6954 · DOI · Paper page
  97. Jank, 2011, Vesicles Generated during Storage of Red Blood Cells Enhance the Generation of Radical Oxygen Speciesin Activated Neutrophils, Sci. World J., 11, 173, 10.1100/tsw.2011.25 · DOI
  98. Danesh, 2014, Exosomes from red blood cell units bind to monocytes and induce proinflammatory cytokines, boosting T-cell responses in vitro, Blood, 123, 687, 10.1182/blood-2013-10-530469 · DOI · Paper page
  99. Hezel, M.E.V., Nieuwland, R., Bruggen, R.V., and Juffermans, N.P. (2017). The Ability of Extracellular Vesicles to Induce a Pro-Inflammatory Host Response. Int. J. Mol. Sci., 18. · DOI
  100. Almizraq, 2016, Extracellular vesicles in transfusion-related immunomodulation and the role of blood component manufacturing, Transf. Apher. Sci., 55, 281, 10.1016/j.transci.2016.10.018 · DOI
  101. Wannez, 2019, Extracellular Vesicles in Red Blood Cell Concentrates: An Overview, Transf. Med. Rev., 33, 125, 10.1016/j.tmrv.2019.02.002 · DOI
  102. Sadallah, 2011, Ectosomes as modulators of inflammation and immunity, Clin. Exp. Immunol., 163, 26, 10.1111/j.1365-2249.2010.04271.x · DOI · Paper page
  103. Straat, 2016, Monocyte-mediated activation of endothelial cells occurs only after binding to extracellular vesicles from red blood cell products, a process mediated by β-integrin, Transfusion, 56, 3012, 10.1111/trf.13851 · doi:10.1111/trf.13851
  104. Fischer, 2017, Microparticles from stored red blood cells enhance procoagulant and proinflammatory activity, Transfusion, 57, 2701, 10.1111/trf.14268 · doi:10.1111/trf.14268
  105. Sadallah, 2008, Erythrocyte-derived ectosomes have immunosuppressive properties, J. Leukoc. Biol., 84, 1316, 10.1189/jlb.0108013 · DOI
  106. Nazimek, 2019, Syngeneic red blood cell–induced extracellular vesicles suppress delayed-type hypersensitivity to self-antigens in mice, Clin. Exp. Allergy, 49, 1487, 10.1111/cea.13475 · DOI
  107. Bradlow, 1961, Liberation of material with platelet-like coagulant properties from intact red cells and particularly from reticulocytes, Br. J. Haematol., 7, 476, 10.1111/j.1365-2141.1961.tb00357.x · doi:10.1111/j.1365-2141.1961.tb00357.x
  108. Horne, 2006, The effect of red blood cells on thrombin generation, Br. J. Haematol., 133, 403, 10.1111/j.1365-2141.2006.06047.x · doi:10.1111/j.1365-2141.2006.06047.x
  109. Diamant, 2004, Cellular microparticles: New players in the field of vascular disease?, Eur. J. Clin. Investig., 34, 392, 10.1111/j.1365-2362.2004.01355.x · DOI · Paper page
  110. Spronk, 2012, Platelet- and erythrocyte-derived microparticles trigger thrombin generation via factor XIIa, J. Thromb. Haemost., 10, 1355, 10.1111/j.1538-7836.2012.04758.x · DOI · Paper page
  111. Koshiar, R.L., Somajo, S., Norstrom, E., and Dahlback, B. (2014). Erythrocyte-derived microparticles supporting activated protein C-mediated regulation of blood coagulation. PLoS ONE, 9. · doi:10.1371/journal.pone.0104200
  112. Levin, 2016, Impact of microparticles derived from erythrocytes on fibrinolysis, J. Thromb Thrombolysis, 41, 452, 10.1007/s11239-015-1299-y · doi:10.1007/s11239-015-1299-y
  113. Amirizadeh, 2019, Procoagulant Activity of Red Blood Cell-Derived Microvesicles during Red Cell Storage, Transfus. Med. Hemother., 46, 224, 10.1159/000494367 · doi:10.1159/000494367
  114. Tzounakas, 2016, Donor variation effect on red blood cell storage lesion: A multivariable, yet consistent, story, Transfusion, 56, 1274, 10.1111/trf.13582 · DOI
  115. Sweeney, 2009, Stored red blood cell supernatant facilitates thrombin generation, Transfusion, 49, 1569, 10.1111/j.1537-2995.2009.02196.x · DOI
  116. Rubin, 2013, Red blood cell-derived microparticles isolated from blood units initiate and propagate thrombin generation, Transfusion, 53, 1744, 10.1111/trf.12008 · DOI
  117. Camus, 2015, Circulating cell membrane microparticles transfer heme to endothelial cells and trigger vasoocclusions in sickle cell disease, Blood, 125, 3805, 10.1182/blood-2014-07-589283 · DOI · Paper page
  118. Freedman, 2003, Nitric oxide and its relationship to thrombotic disorders: Nitric oxide and thrombotic disorders, J. Thromb. Haemost., 1, 1183, 10.1046/j.1538-7836.2003.00180.x · DOI
  119. Devalet, B., Mullier, F., Chatelain, B., Dogné, J.-M., and Chatelain, C. (2014). The central role of extracellular vesicles in the mechanisms of thrombosis in paroxysmal nocturnal haemoglobinuria: A review. J. Extracell Vesicles, 3, (1). · DOI
  120. Yoshida, 2019, Red blood cell storage lesion: Causes and potential clinical consequences, Blood Transfus., 17, 27
  121. Macey, 2011, Flow cytometric analysis of microparticle phenotype and their role in thrombin generation, Cytometry B Clin. Cytom., 80, 57, 10.1002/cyto.b.20551 · doi:10.1002/cyto.b.20551
  122. Berckmans, 2001, Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation, Thromb. Haemost., 85, 639, 10.1055/s-0037-1615646 · DOI · Paper page
  123. Zubairova, 2015, Circulating Microparticles Alter Formation, Structure, and Properties of Fibrin Clots, Sci. Rep., 5, 17611, 10.1038/srep17611 · DOI
  124. Aharon, 2014, Extracellular vesicles in hematological disorders, Rambam Maimonides Med. J., 5, e0032, 10.5041/RMMJ.10166 · DOI
  125. Ataga, 2009, Hypercoagulability and thrombotic complications in hemolytic anemias, Haematologica, 94, 1481, 10.3324/haematol.2009.013672 · DOI · Paper page
  126. Allan, 1982, Release of spectrin-free spicules on reoxygenation of sickled erythrocytes, Nature, 295, 612, 10.1038/295612a0 · DOI
  127. Shet, 2003, Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes, Blood, 102, 2678, 10.1182/blood-2003-03-0693 · DOI · Paper page
  128. Schaap, 2009, Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease, Haematologica, 94, 1513, 10.3324/haematol.2009.008938 · DOI · Paper page
  129. Gerotziafas, 2012, The acceleration of the propagation phase of thrombin generation in patients with steady-state sickle cell disease is associated with circulating erythrocyte-derived microparticles, Thromb. Haemost., 107, 1044, 10.1160/TH11-10-0689 · DOI
  130. Mahfoudhi, 2012, Red cells exchanges in sickle cells disease lead to a selective reduction of erythrocytes-derived blood microparticles, Br. J. Haematol., 156, 545, 10.1111/j.1365-2141.2011.08897.x · doi:10.1111/j.1365-2141.2011.08897.x
  131. Tantawy, 2013, Circulating platelet and erythrocyte microparticles in young children and adolescents with sickle cell disease: Relation to cardiovascular complications, Platelets, 24, 605, 10.3109/09537104.2012.749397 · DOI
  132. Nebor, D., Bowers, A., Connes, P., Hardy-Dessources, M.-D., Knight-Madden, J., Cumming, V., Reid, M., and Romana, M. (2014). Plasma concentration of platelet-derived microparticles is related to painful vaso-occlusive phenotype severity in sickle cell anemia. PLoS ONE, 9. · DOI
  133. Kasar, 2014, Clinical significance of circulating blood and endothelial cell microparticles in sickle-cell disease, J. Thromb. Thrombolysis, 38, 167, 10.1007/s11239-013-1028-3 · DOI
  134. Piccin, 2015, Circulating microparticles, protein C, free protein S and endothelial vascular markers in children with sickle cell anaemia, J. Extracell Vesicles, 4, 28414, 10.3402/jev.v4.28414 · DOI
  135. Hierso, 2017, Exacerbation of oxidative stress during sickle vaso-occlusive crisis is associated with decreased anti-band 3 autoantibodies rate and increased red blood cell-derived microparticle level: A prospective study, Br. J. Haematol., 176, 805, 10.1111/bjh.14476 · DOI
  136. Romana, 2013, Fetal hemoglobin and hydroxycarbamide moduate both plasma concentration and cellular origin of circulating microparticles in sickle cell anemia children, Haematologica, 98, 862, 10.3324/haematol.2012.073619 · DOI
  137. Garnier, Y., Ferdinand, S., Etienne-Julan, M., Elana, G., Petras, M., Doumdo, L., Tressières, B., Lalanne-Mistrih, M.-L., Hardy-Dessources, M.-D., and Connes, P. (2017). Differences of microparticle patterns between sickle cell anemia and hemoglobin SC patients. PLoS ONE, 12. · DOI
  138. Romana, 2018, Microparticles in sickle cell disease, Clin. Hemorheol. Microcirc., 68, 319, 10.3233/CH-189014 · DOI
  139. Taher, 2008, Thalassemia and hypercoagulability, Blood Rev., 22, 283, 10.1016/j.blre.2008.04.001 · DOI · Paper page
  140. Musallam, 2011, Thrombosis in thalassemia: Why are we so concerned?, Hemoglobin, 35, 503, 10.3109/03630269.2011.605499 · DOI
  141. Pattanapanyasat, 2007, Activated platelet-derived microparticles in thalassaemia, Br. J. Haematol., 136, 462, 10.1111/j.1365-2141.2006.06449.x · DOI
  142. Pattanapanyasat, 2004, Flow cytometric quantitation of red blood cell vesicles in thalassemia, Cytometry B Clin. Cytom., 57, 23, 10.1002/cyto.b.10064 · DOI
  143. Habib, 2008, Elevated levels of circulating procoagulant microparticles in patients with beta-thalassemia intermedia, Haematologica, 93, 941, 10.3324/haematol.12460 · doi:10.3324/haematol.12460
  144. Chaichompoo, 2012, Characterizations and proteome analysis of platelet-free plasma-derived microparticles in β-thalassemia/hemoglobin E patients, J. Proteomics, 76, 239, 10.1016/j.jprot.2012.06.004 · DOI
  145. Agouti, 2015, Platelet and not erythrocyte microparticles are procoagulant in transfused thalassaemia major patients, Br. J. Haematol., 171, 615, 10.1111/bjh.13609 · DOI
  146. Tantawy, 2013, Flow cytometric assessment of circulating platelet and erythrocytes microparticles in young thalassemia major patients: Relation to pulmonary hypertension and aortic wall stiffness, Eur. J. Haematol., 90, 508, 10.1111/ejh.12108 · DOI
  147. Kheansaard, 2018, Microparticles from β-thalassaemia/HbE patients induce endothelial cell dysfunction, Sci. Rep., 8, 13033, 10.1038/s41598-018-31386-6 · DOI
  148. Tripodi, 2009, Hypercoagulability in splenectomized thalassemic patients detected by whole-blood thromboelastometry, but not by thrombin generation in platelet-poor plasma, Haematologica, 94, 1520, 10.3324/haematol.2009.010546 · DOI
  149. Macrae, 2018, The prothrombotic state in paroxysmal nocturnal hemoglobinuria: A multifaceted source, Haematologica, 103, 9, 10.3324/haematol.2017.177618 · DOI
  150. Hill, 2013, Thrombosis in paroxysmal nocturnal hemoglobinuria, Blood, 121, 4985, 10.1182/blood-2012-09-311381 · DOI · Paper page
  151. Kozuma, 2011, Procoagulant properties of microparticles released from red blood cells in paroxysmal nocturnal haemoglobinuria, Br. J. Haematol., 152, 631, 10.1111/j.1365-2141.2010.08505.x · doi:10.1111/j.1365-2141.2010.08505.x
  152. Hugel, 1999, Elevated levels of circulating procoagulant microparticles in patients with paroxysmal nocturnal hemoglobinuria and aplastic anemia, Blood, 93, 3451, 10.1182/blood.V93.10.3451.410k27_3451_3456 · DOI · Paper page
  153. Simak, 2004, Elevated circulating endothelial membrane microparticles in paroxysmal nocturnal haemoglobinuria, Br. J. Haematol., 125, 804, 10.1111/j.1365-2141.2004.04974.x · DOI
  154. Ovchynnikova, 2018, The Shape Shifting Story of Reticulocyte Maturation, Front. Physiol., 9, 829, 10.3389/fphys.2018.00829 · DOI
  155. Mankelow, 2015, Autophagic vesicles on mature human reticulocytes explain phosphatidylserine-positive red cells in sickle cell disease, Blood, 126, 1831, 10.1182/blood-2015-04-637702 · DOI
  156. Kalluri, 2016, The biology and function of exosomes in cancer, J. Clin. Investig., 126, 1208, 10.1172/JCI81135 · DOI · Paper page
  157. Fitts, 2019, Exploiting Exosomes in Cancer Liquid Biopsies and Drug Delivery, Adv. Healthc. Mater., 8, e1801268, 10.1002/adhm.201801268 · DOI · Paper page
  158. Zhang, 2017, Characteristics and Roles of Exosomes in Cardiovascular Disease, DNA Cell Biol., 36, 202, 10.1089/dna.2016.3496 · DOI
  159. Jansen, 2017, Exosomes as Diagnostic Biomarkers in Cardiovascular Diseases, Exosomes Cardiovasc. Dis., 998, 61, 10.1007/978-981-10-4397-0_4 · DOI
  160. Kanninen, 2016, Exosomes as new diagnostic tools in CNS diseases, Biochim. Biophys. Acta (BBA) Mol. Basis Dis., 1862, 403, 10.1016/j.bbadis.2015.09.020 · DOI · Paper page
  161. Alipoor, 2016, Exosomes and Exosomal miRNA in Respiratory Diseases, Med. Inflamm., 2016, 1, 10.1155/2016/5628404 · DOI
  162. Masyuk, 2013, Exosomes in the pathogenesis, diagnostics and therapeutics of liver diseases, J. Hepatol., 59, 621, 10.1016/j.jhep.2013.03.028 · DOI · Paper page
  163. Zhang, 2016, Extracellular vesicles in diagnosis and therapy of kidney diseases, Am. J. Physiol. Renal Physiol., 311, F844, 10.1152/ajprenal.00429.2016 · DOI · Paper page
  164. Katakowski, 2013, Exosomes from marrow stromal cells expressing miR-146b inhibit glioma growth, Cancer Lett., 335, 201, 10.1016/j.canlet.2013.02.019 · DOI · Paper page
  165. Mendt, 2018, Generation and testing of clinical-grade exosomes for pancreatic cancer, JCI Insight, 3, e99263, 10.1172/jci.insight.99263 · DOI · Paper page
  166. Shi, 2014, Engineered red blood cells as carriers for systemic delivery of a wide array of functional probes, Proc. Natl. Acad. Sci. USA, 111, 10131, 10.1073/pnas.1409861111 · DOI · Paper page
  167. Malhotra, 2019, Red Blood Cells-Derived Vesicles for Delivery of Lipophilic Drug Camptothecin, ACS Appl. Mater. Interfaces, 11, 22141, 10.1021/acsami.9b04827 · DOI
  168. Chang, 2010, Homologous RBC-derived vesicles as ultrasmall carriers of iron oxide for magnetic resonance imaging of stem cells, Nanotechnology, 21, 235103, 10.1088/0957-4484/21/23/235103 · DOI
  169. Gangadaran, 2018, In vivo Non-invasive Imaging of Radio-Labeled Exosome-Mimetics Derived from Red Blood Cells in Mice, Front. Pharmacol., 9, 817, 10.3389/fphar.2018.00817 · DOI
  170. Iwamoto, 2013, Clinical Application of Drug Delivery Systems in Cancer Chemotherapy: Review of the Efficacy and Side Effects of Approved Drugs, Biol. Pharm. Bull., 36, 715, 10.1248/bpb.b12-01102 · DOI · Paper page
  171. Veronese, 2005, PEGylation, successful approach to drug delivery, Drug Discov. Today, 10, 1451, 10.1016/S1359-6446(05)03575-0 · DOI · Paper page
  172. Ihler, 1973, Enzyme Loading of Erythrocytes, Proc. Natl. Acad. Sci. USA, 70, 2663, 10.1073/pnas.70.9.2663 · DOI · Paper page
  173. Serafini, 2008, Cell-based drug delivery, Adv. Drug Deliv. Rev., 60, 286, 10.1016/j.addr.2007.08.029 · DOI · Paper page
  174. Hamidi, 2003, Carrier Erythrocytes: An Overview, Drug Deliv., 10, 9, 10.1080/713840329 · DOI · Paper page
  175. Dehaini, 2017, Erythrocyte–Platelet Hybrid Membrane Coating for Enhanced Nanoparticle Functionalization, Adv. Mater., 29, 1606209, 10.1002/adma.201606209 · DOI · Paper page
  176. Yoo, 2011, Bio-inspired, bioengineered and biomimetic drug delivery carriers, Nat. Rev. Drug Discov., 10, 521, 10.1038/nrd3499 · DOI · Paper page
  177. Doshi, 2009, Red blood cell-mimicking synthetic biomaterial particles, Proc. Natl. Acad. Sci. USA, 106, 21495, 10.1073/pnas.0907127106 · DOI · Paper page
  178. Tsai, 2010, Self inhibition of phagocytosis: The affinity of ‘marker of self’ CD47 for SIRPα dictates potency of inhibition but only at low expression levels, Blood Cells Mol. Dis., 45, 67, 10.1016/j.bcmd.2010.02.016 · DOI · Paper page
  179. Rauterberg, 1986, Homologous species restriction in lysis of human erythrocytes: A membrane-derived protein with C8-binding capacity functions as an inhibitor, J. Immunol., 136, 1772, 10.4049/jimmunol.136.5.1772 · doi:10.4049/jimmunol.136.5.1772
  180. Zalman, 1986, Isolation of a human erythrocyte membrane protein capable of inhibiting expression of homologous complement transmembrane channels, Proc. Natl. Acad. Sci. USA, 83, 6975, 10.1073/pnas.83.18.6975 · doi:10.1073/pnas.83.18.6975
  181. Kim, 2008, Deficiency of decay-accelerating factor and complement receptor 1–related gene/protein y on murine platelets leads to complement-dependent clearance by the macrophage phagocytic receptor CRIg, Blood, 112, 1109, 10.1182/blood-2008-01-134304 · DOI
  182. Fang, 2012, Nanoparticles disguised as red blood cells to evade the immune system, Expert Opin. Biol. Therapy, 12, 385, 10.1517/14712598.2012.661710 · DOI · Paper page
  183. Hu, 2011, Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform, Proc. Natl. Acad. Sci. USA, 108, 10980, 10.1073/pnas.1106634108 · DOI · Paper page
  184. Tajerzadeh, 2000, Evaluation of hypotonic preswelling method for encapsulation of enalaprilat in intact human erythrocytes, Drug Dev. Ind. Pharm., 26, 1247, 10.1081/DDC-100102306 · doi:10.1081/ddc-100102306
  185. Lynch, 2011, pH-responsive polymers for trehalose loading and desiccation protection of human red blood cells, Biomaterials, 32, 4443, 10.1016/j.biomaterials.2011.02.062 · DOI
  186. Ren, 2016, Red blood cell membrane camouflaged magnetic nanoclusters for imaging-guided photothermal therapy, Biomaterials, 92, 13, 10.1016/j.biomaterials.2016.03.026 · DOI · Paper page
  187. Luk, 2014, Interfacial interactions between natural RBC membranes and synthetic polymeric nanoparticles, Nanoscale, 6, 2730, 10.1039/C3NR06371B · DOI · Paper page
  188. Xia, 2019, Red blood cell membrane-camouflaged nanoparticles: A novel drug delivery system for antitumor application, Acta Pharm. Sin. B, 9, 675, 10.1016/j.apsb.2019.01.011 · DOI · Paper page
  189. Miyazaki, 1998, Gene Transfer into Muscle by Electroporation In Vivo, Gene Therapy Protocols, 69, 49, 10.1385/1-59259-141-8:049 · DOI · Paper page
  190. Zhang, 2015, Synthesis of Nanogels via Cell Membrane-Templated Polymerization, Small, 11, 4309, 10.1002/smll.201500987 · DOI
  191. Su, 2016, Long Circulation Red-Blood-Cell-Mimetic Nanoparticles with Peptide-Enhanced Tumor Penetration for Simultaneously Inhibiting Growth and Lung Metastasis of Breast Cancer, Adv. Funct. Mater., 26, 1243, 10.1002/adfm.201504780 · DOI · Paper page
  192. Martinive, 2006, Reversal of temporal and spatial heterogeneities in tumor perfusion identifies the tumor vascular tone as a tunable variable to improve drug delivery, Mol. Cancer Ther., 5, 1620, 10.1158/1535-7163.MCT-05-0472 · DOI
  193. Sonveaux, 2004, Endothelin-1 is a critical mediator of myogenic tone in tumor arterioles: Implications for cancer treatment, Cancer Res., 64, 3209, 10.1158/0008-5472.CAN-03-1291 · DOI · Paper page
  194. Hamid, 2018, Preparation and optimization of surface-engineered poly(lactic acid) microspheres as a drug delivery device, J. Mater. Sci., 53, 4745, 10.1007/s10853-017-1840-9 · DOI
  195. McCall, 2013, PLGA Nanoparticles Formed by Single- or Double-emulsion with Vitamin E-TPGS, J. Visualized Exp., 82, 51015
  196. Fang, 2014, Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery, Nano Lett., 14, 2181, 10.1021/nl500618u · DOI · Paper page
  197. Lin, 2013, The preparation and characteristic of poly(lactide co-glycolide) microspheres as novel antigen delivery systems, Int. J. Nanotechnol., 10, 870, 10.1504/IJNT.2013.058116 · DOI
  198. Xing, 2016, Ultrasound-Mediated Microbubble Destruction (UMMD) Facilitates the Delivery of CA19-9 Targeted and Paclitaxel Loaded mPEG-PLGA-PLL Nanoparticles in Pancreatic Cancer, Theranostics, 6, 1573, 10.7150/thno.15164 · DOI
  199. Hao, R., Xing, R., Xu, Z., Hou, Y., Gao, S., and Sun, S. (2010). ChemInform Abstract: Synthesis, Functionalization, and Biomedical Applications of Multifunctional Magnetic Nanoparticles. Chem. Inform., 41. · DOI
  200. Sharifi, 2015, Superparamagnetic iron oxide nanoparticles forin vivomolecular and cellular imaging, Contrast Med. Mol. Imaging, 10, 329, 10.1002/cmmi.1638 · DOI

200 of 216 shown

Cited by

See all 164

Metadata

Authors
Thangaraju, K., Neerukonda, S. N., Katneni, U., & Buehler, P. W.
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2020-12-25
Volume
22
Issue
1
Pages
153
ISSN
1422-0067 (ISSN-L)
OpenAlex
W3113596901
Cited by
164
References
24
FWCI
5.26
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Extracellular Vesicles from Red Blood Cells and Their Evolving Roles in Health, Coagulopathy and Therapy. https://app.cochat.ai/papers/10.3390/ijms22010153
The paper
Thangaraju, K., Neerukonda, S. N., Katneni, U., & Buehler, P. W. (2020). Extracellular Vesicles from Red Blood Cells and Their Evolving Roles in Health, Coagulopathy and Therapy. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms22010153

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.